m6A Target Gene Information
General Information of the m6A Target Gene (ID: M6ATAR00248)
Full List of m6A Methylation Regulator of This Target Gene and Corresponding Disease/Drug Response(s)
ETS1
can be regulated by the following regulator(s), and cause disease/drug response(s). You can browse detail information of regulator(s) or disease/drug response(s).
Browse Regulator
Browse Disease
Wilms tumor 1-associating protein (WTAP) [WRITER]
Representative RNA-seq result indicating the expression of this target gene regulated by WTAP | ||
Cell Line | mice hepatocyte | Mus musculus |
Treatment: Wtap Hknockout mice hepatocyte
Control: Wtap flox/flox mice hepatocyte
|
GSE168850 | |
Regulation |
|
logFC: 1.11E+00 p-value: 3.10E-03 |
More Results | Click to View More RNA-seq Results |
In total 1 item(s) under this regulator | ||||
Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene | [1] | |||
Response Summary | WTAP-guided m6A modification contributes to the progression of Hepatocellular carcinoma cells via the HuR-Protein C-ets-1 (ETS1)-p21/p27 axis. | |||
Target Regulation | Down regulation | |||
Responsed Disease | Hepatocellular carcinoma | ICD-11: 2C12.02 | ||
Pathway Response | Cell cycle | hsa04110 | ||
Cell Process | Cell proliferation and tumor growth | |||
Cell apoptosis | ||||
Arrest cell cycle at G2/M phase | ||||
In-vitro Model | HCCLM3 | Adult hepatocellular carcinoma | Homo sapiens | CVCL_6832 |
Hep 3B2.1-7 | Childhood hepatocellular carcinoma | Homo sapiens | CVCL_0326 | |
Huh-7 | Adult hepatocellular carcinoma | Homo sapiens | CVCL_0336 | |
MHCC97-H | Adult hepatocellular carcinoma | Homo sapiens | CVCL_4972 | |
PLC/PRF/5 | Adult hepatocellular carcinoma | Homo sapiens | CVCL_0485 | |
QSG-7701 | Endocervical adenocarcinoma | Homo sapiens | CVCL_6944 | |
SMMC-7721 | Endocervical adenocarcinoma | Homo sapiens | CVCL_0534 | |
In-vivo Model | 3 × 106 treated HCC cells resuspended in 100 uL PBS were subcutaneously injected to the left flank of the mice, which were randomly divided into several groups. Tumor sizes were measured every 3 to 5 days. | |||
Liver cancer [ICD-11: 2C12]
In total 1 item(s) under this disease | ||||
Experiment 1 Reporting the m6A-centered Disease Response | [1] | |||
Response Summary | WTAP-guided m6A modification contributes to the progression of Hepatocellular carcinoma cells via the HuR-Protein C-ets-1 (ETS1)-p21/p27 axis. | |||
Responsed Disease | Hepatocellular carcinoma [ICD-11: 2C12.02] | |||
Target Regulator | Wilms tumor 1-associating protein (WTAP) | WRITER | ||
Target Regulation | Down regulation | |||
Pathway Response | Cell cycle | hsa04110 | ||
Cell Process | Cell proliferation and tumor growth | |||
Cell apoptosis | ||||
Arrest cell cycle at G2/M phase | ||||
In-vitro Model | HCCLM3 | Adult hepatocellular carcinoma | Homo sapiens | CVCL_6832 |
Hep 3B2.1-7 | Childhood hepatocellular carcinoma | Homo sapiens | CVCL_0326 | |
Huh-7 | Adult hepatocellular carcinoma | Homo sapiens | CVCL_0336 | |
MHCC97-H | Adult hepatocellular carcinoma | Homo sapiens | CVCL_4972 | |
PLC/PRF/5 | Adult hepatocellular carcinoma | Homo sapiens | CVCL_0485 | |
QSG-7701 | Endocervical adenocarcinoma | Homo sapiens | CVCL_6944 | |
SMMC-7721 | Endocervical adenocarcinoma | Homo sapiens | CVCL_0534 | |
In-vivo Model | 3 × 106 treated HCC cells resuspended in 100 uL PBS were subcutaneously injected to the left flank of the mice, which were randomly divided into several groups. Tumor sizes were measured every 3 to 5 days. | |||